Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, June 6, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Life Sciences Times
-
June 8, 2021
0
People on the Move
Biomedical Informatics Leader Erich Huang Joins Onduo as Chief Science and Innovation Officer
Life Sciences Times
-
June 7, 2021
0
Pharma
Lennham Pharmaceuticals Announces Topline Results from Pharmacokinetic Study of d9-Caffeine Versus Caffeine
Life Sciences Times
-
June 7, 2021
0
Life Sciences
Entegris Expands Life Sciences Production Capacity and Capabilities
Life Sciences Times
-
June 7, 2021
0
Real Estate
Boston Properties Builds on Its Growing Life Sciences Portfolio, Acquires Lab Properties in Waltham, Massachusetts
Life Sciences Times
-
June 4, 2021
0
Pharma
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
Life Sciences Times
-
June 4, 2021
0
Pharma
Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Life Sciences Times
-
June 4, 2021
0
People on the Move
Janux Therapeutics Appoints Dr. Wayne Godfrey as Chief Medical Officer
Life Sciences Times
-
June 3, 2021
0
Venture Capital
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer
Life Sciences Times
-
June 3, 2021
0
1
...
602
603
604
...
654
Page 603 of 654
Most Popular
IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders
June 5, 2025
Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth
June 5, 2025
Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis
June 5, 2025
Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds
June 5, 2025
Load more
Recent Comments
Recent Comments